A Study of LY4515100 in Healthy Male Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main purpose of this study is to evaluate how the body handles \[¹⁴C\]-LY4515100. The study will investigate how much \[¹⁴C\]-LY4515100 enters the bloodstream from the stomach or intestines and is available to have an effect on the body, how the body changes \[¹⁴C\]-LY4515100 so that it can be used or removed, and how the body gets rid of \[¹⁴C\]-LY4515100. For each participant, the study will last about 9 weeks and will include a Clinical Research Unit (CRU) stay lasting between 10 and 30 days.
Epistemonikos ID: e115967004d934cf0ebcd147a774cab5a43a2a7b
First added on: Oct 10, 2026